Table 1.
In vitro efficacy of different Quillaja saponaria extracts against ISAv infections in ASK cells.
| Product | Product concentration (μg/mL) | Saponin concentration (μg/mL) | Viral copies/mL (104) | Infection inhibition (%) |
|---|---|---|---|---|
| Control | 0 | 0 | 870.818+/−15.903 | 0a |
| VaxSap® | 0.48 | 0.43 | 0.0005+/−0.0003 | >99b |
| PPQ | 0.48 | 0.31 | 44.800+/−24.335 | 95b |
| NPQ | 0.48 | 0.12 | 0.010+/−0.007 | >99b |
Data are presented as mean ± SD. Statistical analysis was performed using one-way ANOVA followed by Tukey’s post-hoc test. Different superscript letters (a, b) indicate statistically significant differences between groups at p < 0.05.